Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $20.6 million.

  • Perspective Therapeutics' Total Current Liabilities fell 2673.84% to $20.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year decrease of 2673.84%. This contributed to the annual value of $18.2 million for FY2024, which is 1638.15% up from last year.
  • According to the latest figures from Q3 2025, Perspective Therapeutics' Total Current Liabilities is $20.6 million, which was down 2673.84% from $13.0 million recorded in Q2 2025.
  • Perspective Therapeutics' 5-year Total Current Liabilities high stood at $28.1 million for Q3 2024, and its period low was $1.8 million during Q3 2021.
  • For the 5-year period, Perspective Therapeutics' Total Current Liabilities averaged around $9.3 million, with its median value being $8.1 million (2023).
  • Per our database at Business Quant, Perspective Therapeutics' Total Current Liabilities soared by 40237.33% in 2023 and then crashed by 2673.84% in 2025.
  • Over the past 5 years, Perspective Therapeutics' Total Current Liabilities (Quarter) stood at $1.8 million in 2021, then surged by 69.0% to $3.1 million in 2022, then soared by 402.37% to $15.7 million in 2023, then rose by 16.38% to $18.2 million in 2024, then rose by 13.1% to $20.6 million in 2025.
  • Its Total Current Liabilities was $20.6 million in Q3 2025, compared to $13.0 million in Q2 2025 and $12.7 million in Q1 2025.